BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29550174)

  • 1. The oral administration of clarithromycin prevents the progression and rupture of aortic aneurysm.
    Uchida W; Narita Y; Yamawaki-Ogata A; Tokuda Y; Mutsuga M; Lee Fujimoto K; Abe T; Oshima H; Usui A
    J Vasc Surg; 2018 Dec; 68(6S):82S-92S.e2. PubMed ID: 29550174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice.
    Hashizume R; Yamawaki-Ogata A; Ueda Y; Wagner WR; Narita Y
    J Vasc Surg; 2011 Dec; 54(6):1743-52. PubMed ID: 21908146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse.
    Fu XM; Yamawaki-Ogata A; Oshima H; Ueda Y; Usui A; Narita Y
    J Transl Med; 2013 Jul; 11():175. PubMed ID: 23875706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of bone marrow-derived mesenchymal stem cells in formed aortic aneurysms of a mouse model.
    Yamawaki-Ogata A; Fu X; Hashizume R; Fujimoto KL; Araki Y; Oshima H; Narita Y; Usui A
    Eur J Cardiothorac Surg; 2014 May; 45(5):e156-65. PubMed ID: 24554076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell-derived conditioned medium attenuate angiotensin II-induced aortic aneurysm growth by modulating macrophage polarization.
    Zhou YZ; Cheng Z; Wu Y; Wu QY; Liao XB; Zhao Y; Li JM; Zhou XM; Fu XM
    J Cell Mol Med; 2019 Dec; 23(12):8233-8245. PubMed ID: 31583844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB.
    Parodi FE; Mao D; Ennis TL; Bartoli MA; Thompson RW
    J Vasc Surg; 2005 Mar; 41(3):479-89. PubMed ID: 15838484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
    Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
    Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Induces M2 Macrophage Polarization and Inhibits Murine Aortic Aneurysm Formation.
    Kawai Y; Narita Y; Yamawaki-Ogata A; Usui A; Komori K
    Biomed Res Int; 2019; 2019():9104680. PubMed ID: 31263710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of salvianolic acid C on aortic structure in apolipoprotein E-deficient mice treated with angiotension II.
    Wu P; Han N; Yu H; Wang L; Li X; Dong Z; Fu W; Yorinaka H; Cho K; Wu W; Liu X; Yang M; Guo DA; Yin J; Jiang B
    Life Sci; 2016 Dec; 166():75-81. PubMed ID: 27663582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
    Zhang XJ; He C; Tian K; Li P; Su H; Wan JB
    Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvianolic acid A, a matrix metalloproteinase-9 inhibitor of Salvia miltiorrhiza, attenuates aortic aneurysm formation in apolipoprotein E-deficient mice.
    Zhang T; Xu J; Li D; Chen J; Shen X; Xu F; Teng F; Deng Y; Ma H; Zhang L; Zhang G; Zhang Z; Wu W; Liu X; Yang M; Jiang B; Guo D
    Phytomedicine; 2014 Sep; 21(10):1137-45. PubMed ID: 24916705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells prevent angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E knockout mice.
    Meng X; Yang J; Zhang K; An G; Kong J; Jiang F; Zhang Y; Zhang C
    Hypertension; 2014 Oct; 64(4):875-82. PubMed ID: 25024283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent Molecular Magnetic Resonance Imaging of Inflammatory Activity and Extracellular Matrix Degradation for the Prediction of Aneurysm Rupture.
    Brangsch J; Reimann C; Kaufmann JO; Adams LC; Onthank DC; Thöne-Reineke C; Robinson SP; Buchholz R; Karst U; Botnar RM; Hamm B; Makowski MR
    Circ Cardiovasc Imaging; 2019 Mar; 12(3):e008707. PubMed ID: 30871334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis.
    Krishna SM; Seto SW; Jose RJ; Li J; Morton SK; Biros E; Wang Y; Nsengiyumva V; Lindeman JH; Loots GG; Rush CM; Craig JM; Golledge J
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):553-566. PubMed ID: 28062506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the mechanisms by which 3,4-benzopyrene promotes angiotensin II-induced abdominal aortic aneurysm formation in mice.
    Ji K; Zhang Y; Jiang F; Qian L; Guo H; Hu J; Liao L; Tang J
    J Vasc Surg; 2014 Feb; 59(2):492-9. PubMed ID: 23676189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.
    Davis FM; Rateri DL; Balakrishnan A; Howatt DA; Strickland DK; Muratoglu SC; Haggerty CM; Fornwalt BK; Cassis LA; Daugherty A
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):155-62. PubMed ID: 25395615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Jun-terminal-N-kinase in endothelial cells.
    Marinkovic G; Hibender S; Hoogenboezem M; van Broekhoven A; Girigorie AF; Bleeker N; Hamers AA; Stap J; van Buul JD; de Vries CJ; de Waard V
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2380-8. PubMed ID: 23950142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse.
    Krishna SM; Seto SW; Jose RJ; Biros E; Moran CS; Wang Y; Clancy P; Golledge J
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):389-98. PubMed ID: 25524772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin accelerates aortic enlargement and promotes dissection and rupture in Marfan mice.
    LeMaire SA; Zhang L; Zhang NS; Luo W; Barrish JP; Zhang Q; Coselli JS; Shen YH
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):e215-e226. PubMed ID: 34586071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.